Archive Newsletter
-
04.02.24 -- CRISPR Therapies And The Regulatory Landscape
4/2/2024
04/02/24 Advancing RNA Newsletter
-
03.28.24 -- Optimize Your Drug Development With GPS Engineering
3/28/2024
03/28/24 Advancing RNA Newsletter
-
03.27.24 -- FDA's Gene Editing Guidance: New & Remaining Questions
3/27/2024
03/27/24 Advancing RNA Newsletter
-
03.25.24 -- End-To-End Services And Solutions For Your RNA Manufacturing
3/25/2024
03/25/24 Advancing RNA Newsletter
-
03.20.24 -- Shakespeare's Guide To RNA Therapeutics GMP Principles
3/20/2024
03/20/24 Advancing RNA Newsletter
-
03.14.24 -- Regulatory & GMP Manufacturing Insights Into mRNA-LNP Drug Products
3/14/2024
03/14/24 Advancing RNA Newsletter
-
03.13.24 -- mRNA Meets Violin Making: What Can We Learn From Violin Makers?
3/13/2024
03/13/24 Advancing RNA Newsletter
-
03.06.24 -- "Plug & Play" Lessons For RNA Companies
3/6/2024
03/06/24 Advancing RNA Newsletter
-
02.28.24 -- "Endless RNA" Company Sail Biomedicines On Managing Mergers
2/28/2024
02/28/24 Advancing RNA Newsletter
-
02.26.24 -- Hi-Quality INDe sgRNAs For Preclinical Safety
2/26/2024
02/26/24 Advancing RNA Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more